Icon
+91 94997 68112
Login Register

SPRITAM - (250MG, 500MG, 750MG, 1000MG ; Tablet, For Solution)

LEVETIRACETAM APRECIA PHARMS
250MG, 500MG, 750MG, 1000MG ; Tablet, For Solution
Less Than $1000 mn
None None
Less Than 5
 None
None None
SPRITAM is indicated for the treatment of partial-onset seizures in patients 4 years of age and older weighing more than 20 kg SPRITAM is indicated for adjunctive therapy for the treatment of: • Myoclonic seizures in patients 12 years of age and older with juvenile myoclonic epilepsy • Primary generalized tonic-clonic seizures in patients 6 years of age and older with idiopathic generalized epilepsy.
Yes
SPRITAM Patent 1 Patent 2 Patent 3 Patent 4 Patent 5
*** *********
****** **** ********** ***** ******** **********, ******* ** *** *** ******* *** *** *********** ** **** ****** **** ********** ***** ******** **********, ******* ** *** *** ******* *** *** *********** ** **** ***** ******** ****** **** ***** ******** ****** **** ********** ************* ***** ******** ****** **** ********** *************

Download ParaIV Report

Download ParaIV Detailed Report

To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.

Headquarters

Research Delta Advisor, G4,Sani Apartment, Bank of india lane, Ellora park, Vadodara 390023

+91 94997 68112

nimish@researchdelta.com

Products & Services

Para IV GenUS Pharmalysis Consulting Valuation

Quick Links

Home About Career Media Coverage Contact
© Research Delta, All Right Reserved.   Privacy Policy.   Terms and Conditions.